Raab & Moskowitz Asset Management’s Roivant Sciences ROIV Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Hold	11,000	–	–	0.08%	153
2026 Q1	$305K	Hold	11,000	–	–	0.07%	164
2025 Q4	$239K	Hold	11,000	–	–	0.05%	179
2025 Q3	$166K	Hold	11,000	–	–	0.04%	187
2025 Q2	$124K	Hold	11,000	–	–	0.03%	184
2025 Q1	$111K	Hold	11,000	–	–	0.03%	174
2024 Q4	$130K	Hold	11,000	–	–	0.03%	169
2024 Q3	$127K	Buy	+11,000	New	+$125K	0.03%	167

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Raab & Moskowitz Asset Management's ROIV Position: Q2 2026 in Review

Raab & Moskowitz Asset Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 11,000 shares worth $389K. The position accounts for 0.08% of the portfolio, ranked #153.

Raab & Moskowitz Asset Management first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Raab & Moskowitz Asset Management held 11,000 shares of Roivant Sciences worth $389K as of Q2 2026.
Raab & Moskowitz Asset Management left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 0.08% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #153 holding.
Raab & Moskowitz Asset Management first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.